Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Trading Update

7 Jan 2013 07:00

RNS Number : 9109U
PureCircle Limited
07 January 2013
 



PURECIRCLE LIMITED

 

TRADING UPDATE

 

PureCircle (LSE: PURE), the world's largest producer and marketer of high purity stevia ingredients, today provides a trading update in respect of the six month period from 1 July 2012 to 31 December 2012, being the first half of its Financial Year 2013 (1H FY13). The Company's interim results for 1H FY13 will be announced on Wednesday 13 March 2013.

Sales

Sales in 1H FY13 are expected to be $27.3m, an increase of 80% against 1H FY12 ($15.2m). $26m of the sales are expected to be high purity stevia sweeteners and natural flavors, a 120% improvement against 1H FY12.There was growth in sales across all high purity ingredients primarily driven by new innovations in our Stevia PureCircle proprietary portfolio of all-natural, no-calorie sweeteners and natural flavor systems, under the PureCircle Flavors range.  By region, EMEA, Latin America, Asia Pacific and USA all recorded sales growth.

Sales volumes: In 1H FY13 total volumes of high purity stevia sweeteners and natural flavors are expected to increase by 135% against 1H FY12. Volume increases were led by sales of new proprietary ingredients introduced over the past twenty-four months.

 

EBITDA

The benefits of the increase in sales are expected to flow through the Profit and Loss account. Overall 1H FY13 EBITDA is expected to show an 80% improvement against 1H FY12 (EBITDA loss of $8.9m).

Cash, net debt and funding headroom

The Group ended 1H FY13 with gross cash of $45m, net debt of $67m and cash and facility headroom of $70m. The Group is sufficiently funded for its current expansion plans.

 

Commenting on the 1H FY13 trading, the Group CEO Magomet Malsagov said:  Our strategy of having a fully controlled, vertically integrated supply chain from leaf to finished products, of successfully developing and introducing to the market new proprietary natural sweeteners and flavors, of investing in applications and formulations as well as in global marketing and customer service capabilities, is beginning to yield results as can be seen by our performance in the first half of this fiscal year. New long term supply and joint development agreements with major global food and beverage (F&B) companies have been signed adding to our already strong portfolio of Global Key Accounts. Across the world, large F&B brands began to adopt our ingredients, most notably carbonated soft drinks (CSD's) including the important Cola category. We generate revenues from a wide range of natural sweeteners and flavors and we service globally hundreds of customers directly and through our business partners.

Our production capacity and customer service infrastructure are designed to deliver even greater volumes and revenues. As we continue to build on recent momentum, our guidance for sustained higher levels of market demand remains mid to long-term based.

Enquiries:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, CEO

+603 2166 2066

William Mitchell, CFO

+44 7974 005 163

RFC Ambrian Ltd (NOMAD)

+61 8 9480 2500

Stephen Allen

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTNKADNCBKDQDK
Date   Source Headline
20th Sep 20167:00 amRNSFinal Results
12th Aug 20167:00 amRNSNotice of Results
29th Jul 201611:57 amRNSTotal Voting Rights
14th Jul 201611:10 amRNSDirector/PDMR Shareholding
14th Jul 201611:10 amRNSDirector/PDMR Shareholding
14th Jul 201611:09 amRNSDirector/PDMR Shareholding
14th Jul 201611:08 amRNSDirector/PDMR Shareholding
14th Jul 201611:08 amRNSDirector/PDMR Shareholding
13th Jul 20163:56 pmRNSDirector/PDMR Shareholding
12th Jul 20167:00 amRNSResignation of Chief Operating Officer
8th Jul 20167:00 amRNSAdditional Listing
6th Jul 20167:00 amRNSTrading Update and Board of Director Changes
29th Jun 20167:00 amRNSUS Customs and Border Protection Update
27th Jun 20167:57 amRNSCompany Secretary Change
2nd Jun 20168:25 amRNSU.S Customs and Border Protection Communication
23rd May 201610:42 amRNSDirector/PDMR Shareholding
29th Apr 20168:55 amRNSTotal Voting Rights
18th Apr 201610:13 amRNSDirector/PDMR Shareholding
15th Apr 20167:00 amRNSChange of Brokers
5th Apr 20167:00 amRNSTrading Statement
4th Apr 20167:00 amRNSDirectorate Change
31st Mar 20169:01 amRNSTotal Voting Rights
21st Mar 20169:07 amRNSDirector/PDMR Shareholding
14th Mar 20168:36 amRNSDirector/PDMR Shareholding
10th Mar 201610:47 amRNSDirector/PDMR Shareholding
4th Mar 20167:00 amRNSDirector/PDMR Shareholding
1st Mar 20167:00 amRNSHalf Yearly Report
18th Feb 20167:00 amRNSRecruitment of New Chief Financial Officer
17th Feb 20169:33 amRNSNotice of Results
4th Feb 20168:23 amRNSHolding(s) in Company
20th Jan 20167:00 amRNSAppointment of PWC London as auditor
6th Jan 20167:00 amRNSTrading Statement
23rd Dec 20159:22 amRNSDirector/PDMR Shareholding
18th Dec 20157:00 amRNSReb M Approval Milestone Achieved In Europe
14th Dec 20157:00 amRNSPureCircle Launches Zeta Family of New Ingredients
2nd Dec 20159:17 amRNSResult of AGM
2nd Dec 20157:55 amRNSDirector/PDMR Shareholding
24th Nov 20157:00 amRNSApproval of High Purity Stevia in India
20th Nov 20158:33 amRNSDirector/PDMR Shareholding
6th Nov 20157:00 amRNSNotice of AGM
28th Oct 20157:00 amRNSFirst Day of Dealings on Main Market
22nd Oct 20151:17 pmRNSPublication of Prospectus and Listing Update
19th Oct 201511:10 amRNSResult of Special General Meeting
16th Oct 20157:00 amRNSExercise of Options
12th Oct 20157:00 amRNSPureCircle to be Granted Patent
29th Sep 20157:01 amRNSExercise of options
21st Sep 20157:00 amRNS2015 Results& Intention to list on LSE Main Market
15th Sep 201511:33 amRNSFY15 Results Announcement and Capital Markets Day
10th Jul 20157:00 amRNSBoard Changes
7th Jul 20157:00 amRNSLTIP Update - Options Lapse, Grant and Exercise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.